Study on association between serum tumor markers and bone metastasis in HER 2-positive breast cancer

WANGZijia,HEYingjian,LIJinfeng,XIEYuntao,WANGTianfeng,FANZhaoqing,FANTie,OUYANGTao

DOI: https://doi.org/10.3969/j.issn.1673-4130.2016.14.004

2016-01-01

Abstract:Objective To investigate the association between tumor marker level and bone metastasis in HER 2‐positive breast cancer .Methods One hundrend patients with HER2‐positive breast cancer were collected and divided into the bone metastasis group(n=40) and non‐bone metastasis group(n=60) .The enzyme‐linked immunosorbent assay(ELISA) was adopted to monitor serum CA153 and CEA levels at admission and at the time for discovering bone metastasis .The age ,pathological classification ,and application situation of serum tumor marker and herceptin were observed .The differences of above indicators were compared be‐tween the two groups .The receiver‐operating characteristic (ROC) curve was used to evaluate the value of serum CA 153 and CEA for predicting bone metastasis in HER2‐positive breast cancer .Results The levels of serum CEA and CA153 at admission had no statistically significant difference between with and without bone metastasis in the patients with HER 2 positive breast cancer .The ROC curve showed that the levels of serum CEA (AUC 0 .72 ,95% CI 0 .72 to 0 .63 ,P=0 .01) and CA153 (AUC 0 .67 ,95% CI 0 .67 to 0 .60 ,P=0 .03) were the factors for predicting bone metastases .The sensitivity and specificity of CA153>17 .2 U/mL for predicting bone metastases were 78 .8% and 45 .0% respectively ;the sensitivity and specificity of CEA >2 .64 μg/L for predicting bone metastases were 75 .8% ,and 43 .3% ,respectively .Conclusion The serum CEA and CA153 levels have a certain value for pre‐dicting bone metastasis in the patients with HER2度positive breast cancer .